SBIR Phase 1: Mimicking Synuclein Toxicity in Plant Cells to Identify Novel Neuroprotective Leads

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/181/31/20

Funding

  • Naprogenix: $73,705.00